132 related articles for article (PubMed ID: 10962296)
1. Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation.
El Fettouh HA; Cook DJ; Bishay E; Flechner S; Goldfarb D; Modlin C; Dennis V; Novick AC
Urology; 2000 Sep; 56(3):369-72. PubMed ID: 10962296
[TBL] [Abstract][Full Text] [Related]
2. The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients.
Kotb M; Russell WC; Hathaway DK; Gaber LW; Gaber AO
Clin Transplant; 1999 Feb; 13(1 Pt 2):83-9. PubMed ID: 10081642
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
4. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
[TBL] [Abstract][Full Text] [Related]
5. Impaired renal graft survival after a positive B-cell flow-cytometry crossmatch.
Bittencourt MC; Rebibou JM; Saint-Hillier Y; Chabod J; Dupont I; Chalopin JM; Herve P; Tiberghien P
Nephrol Dial Transplant; 1998 Aug; 13(8):2059-64. PubMed ID: 9719165
[TBL] [Abstract][Full Text] [Related]
6. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two drug regimens upon clinical outcome among renal transplant recipients with positive flow cytometric crossmatches.
Kimball P; Wagner B; King A; Fisher RA; Dawson S; Cotterell A; Posner M
Clin Transplant; 2002 Aug; 16(4):290-4. PubMed ID: 12099986
[TBL] [Abstract][Full Text] [Related]
8. Identification of high- and low-risk second kidney grafts.
Mahoney RJ; Norman DJ; Colombe BW; Garovoy MR; Leeber DA
Transplantation; 1996 May; 61(9):1349-55. PubMed ID: 8629295
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.
O'Rourke RW; Osorio RW; Freise CE; Lou CD; Garovoy MR; Bacchetti P; Ascher NL; Melzer JS; Roberts JP; Stock PG
Clin Transplant; 2000 Apr; 14(2):167-73. PubMed ID: 10770424
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
Karpinski M; Rush D; Jeffery J; Exner M; Regele H; Dancea S; Pochinco D; Birk P; Nickerson P
J Am Soc Nephrol; 2001 Dec; 12(12):2807-2814. PubMed ID: 11729251
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.
Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD
Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry.
Cook DJ; Fettouh HI; Gjertson DW; Cecka JM
Clin Transpl; 1998; ():413-9. PubMed ID: 10503119
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of flow cytometry crossmatching in heart transplantation.
Bishay ES; Cook DJ; Starling RC; Ratliff NB; White J; Blackstone EH; Smedira NG; McCarthy PM
Eur J Cardiothorac Surg; 2000 Apr; 17(4):362-9. PubMed ID: 10773556
[TBL] [Abstract][Full Text] [Related]
14. Acute humoral rejection of kidney allografts in patients with a positive flow cytometry crossmatch (FCXM).
Takeda A; Uchida K; Haba T; Tominaga Y; Katayama A; Kobayashi T; Oikawa T; Morozumi K
Clin Transplant; 2000; 14 Suppl 3():15-20. PubMed ID: 11092347
[TBL] [Abstract][Full Text] [Related]
15. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
[TBL] [Abstract][Full Text] [Related]
16. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation.
Ogura K; Terasaki PI; Johnson C; Mendez R; Rosenthal JT; Ettenger R; Martin DC; Dainko E; Cohen L; Mackett T
Transplantation; 1993 Aug; 56(2):294-8. PubMed ID: 8356583
[TBL] [Abstract][Full Text] [Related]
17. The flow cytometric crossmatch and early renal transplant loss.
Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J
Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366
[TBL] [Abstract][Full Text] [Related]
18. T-cell flow-cytometry crossmatch and long-term renal graft survival.
Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
[TBL] [Abstract][Full Text] [Related]
20. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch.
Lazda VA
Transplantation; 1994 Mar; 57(6):964-9. PubMed ID: 8154047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
